Merck & Company, Inc. Total Debt 2007–2025
Merck & Company, Inc. reported $49.34B of total debt (short- plus long-term borrowings) for fiscal 2025. That was 32.9% higher than fiscal 2024. Compared with fiscal 2020, the change was +55.2%.
| Fiscal year | Total Debt | Change (YoY) |
|---|---|---|
| FY 2025 | $49.34B | +32.9% |
| FY 2024 | $37.11B | +5.9% |
| FY 2023 | $35.05B | +14.2% |
| FY 2022 | $30.69B | -7.3% |
| FY 2021 | $33.10B | +4.1% |
| FY 2020 | $31.79B | +20.7% |
| FY 2019 | $26.35B | +4.9% |
| FY 2018 | $25.11B | +2.9% |
| FY 2017 | $24.41B | -1.7% |
| FY 2016 | $24.84B | -5.9% |
| FY 2015 | $26.41B | +23.4% |
| FY 2014 | $21.40B | -14.6% |
| FY 2013 | $25.06B | +21.8% |
| FY 2012 | $20.57B | +17.4% |
| FY 2011 | $17.52B | -2.1% |
| FY 2010 | $17.88B | -5.3% |
| FY 2009 | $18.88B | +202.5% |
| FY 2008 | $6.24B | — |
| FY 2007 | $0 | — |
Source: Merck & Company, Inc. SEC filings — balance sheet (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open MRK 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Merck & Company, Inc. reported $49.34B of total debt (short- plus long-term borrowings) for fiscal 2025. That was 32.9% higher than fiscal 2024. Compared with fiscal 2020, the change was +55.2%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Merck & Company, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeMerck & Company, Inc. — frequently asked questions
What is Merck & Company, Inc.'s total debt (short- plus long-term borrowings)?
Merck & Company, Inc. (MRK) reported total debt (short- plus long-term borrowings) of $49.34B for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Merck & Company, Inc.'s official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.
More MRK financial history
Full MRK fundamentals page → · Analyze total debt (short- plus long-term borrowings) with a free tool → · All 1,500+ companies →